BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16

• Press Releases

  ANI Pharmaceuticals Announces Positive Six-Month Topline Data from the Phase 4 Open-Label, Single-Arm SYNCHRONICITY Trial Evaluating Fluocinolone Acetonide Intravitreal Implant in Patients with Chronic Non-Infectious Uveitis

  July 13, 2026

   · 

  14 min read
• Press Releases

  U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma

  July 13, 2026

   · 

  7 min read
• Press Releases

  Ocugen, Inc. Announces Binding Term Sheet with Roots Pharmaceutical to License OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in the Middle East and North Africa

  July 13, 2026

   · 

  5 min read
• Press Releases

  Longeveron Announces Presentation of Clinical Data at the 2026 Alzheimer’s Association International Conference (AAIC) that Indicate Its Cellular Therapy Laromestrocel Reduced Neuroinflammation in Patients with Alzheimer’s Disease

  July 13, 2026

   · 

  10 min read
• Press Releases

  VERAXA Biotech to Launch AI-enabled Drug Discovery Collaboration with Ardigen to Support Growing BiTAC® Pipeline

  July 13, 2026

   · 

  5 min read
• Press Releases

  EyePoint Appoints Tarek S. Hassan, M.D., as Chief Strategic Science Officer

  July 13, 2026

   · 

  10 min read
• Press Releases

  Tonix Pharmaceuticals Announces Major Managed Medicare Payer Agreement for TONMYA®

  July 13, 2026

   · 

  13 min read
• Press Releases

  Kamada Highlights CYTOGAM® Study Results Presented at the 2026 ISHLT Annual Meeting

  July 13, 2026

   · 

  9 min read
• Press Releases

  Adlai Nortye Expands Scientific Advisory Board with Appointment of Two Leading Medical Oncologists

  July 13, 2026

   · 

  5 min read
• Press Releases

  Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults With Narcolepsy Type 1 and Type 2 in Long-Term Extension Study Interim Analysis

  July 13, 2026

   · 

  12 min read